期刊文献+

二十五味珊瑚胶囊合整脊对椎动脉型颈椎病患者神经降压素的影响 被引量:3

Effects of Neurotensin in Vertebral Artery Type of Cervical Spondylosis by Manipulation Therapy and Jinzhuyalong Ershiwuwei Coral Capsule
下载PDF
导出
摘要 目的探讨二十五味珊瑚胶囊合并整脊治疗对椎动脉型颈椎病的临床疗效和神经降压素变化(NT)及作用。方法选择90例椎动脉型颈椎病患者为观察组,随机分为常规治疗亚组(45例)和联合治疗亚组(45例),常规治疗亚组采用常规整脊治疗,联合治疗亚组在常规治疗基础上加二十五味珊瑚胶囊口服治疗;选择健康体检45例为对照组。通过放射免疫测定法(RIA)对治疗前后及健康组人员神经降压素含量进行测定。结果观察组治疗后NT含量均高于治疗前,尤以联合治疗亚组NT升高显著,两亚组比较差异有统计学意义(P<0.05),均低于健康组NT。结论血浆内神经降压素降低是造成颈椎源性椎动脉持续缺血的重要因素,二十五味珊瑚胶囊合并整脊疗法治疗椎动脉型颈椎病有效,可通过提高血浆神经降压素水平而改善椎动脉持续缺血。 Objective To study the changes and effects of plasme neurotensin (NT)in vertebral artery type of cervical spondylosis patients by manipulation therapy and Jinzhuyalong Ershiwuwei Coral Capsule.Methods Before and after manipulation therapy and Jinzhuyalong Ershiwuwei Coral Capsule,the levels of NT in the plasma of vertebral artery type of cervical spondylosis group and normal contrast group were detected by radioimmunoassay(RIA).Results The levels of NT in the plasma was significantly decreased in vertebral artery type of cervical spondylosis group compared with those in the control group(P<0.05).After the manipulation therapy or Jinzhuyalong Ershiwuwei Coral Capsule therapy ,the levels of plasma NT in vertebral artery type of cervical spondylosis group was notably increased (P<0.05).Conclusions The decrease of NT in the plasma is a important factor which causes continue ischemia of vertebral artery in cervical spondylosis.The manipulation therapy and Jinzhuyalong Ershiwuwei Coral Capsule therapy therapy can improve blood-suppy of vertebral artery by increaseing the levels of NT in plasma.
出处 《中国中医药现代远程教育》 2013年第7期13-15,共3页 Chinese Medicine Modern Distance Education of China
关键词 二十五味珊瑚胶囊 整脊治疗 椎动脉型颈椎病 神经降压素 中医药疗法 Vertebral artery type of cervical spondylosis Manipulation therapy Jinzhuyalong Ershiwuwei Coral Capsule Neurotensin
  • 相关文献

参考文献7

二级参考文献72

  • 1杜冠华,张均田.丹酚酸A对小鼠脑缺血再灌注致学习记忆功能障碍的改善作用及作用机制[J].药学学报,1995,30(3):184-190. 被引量:84
  • 2崔瑞耀 战翠英.高血压大鼠中枢神经系统与血浆神经降压素含量的分析[J].中国病理生理杂志,1993,3:749-749.
  • 3[1]Morris MJ,Cox HS,Lambert GW,et al.Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.Hypertension,1997,29:137-143.
  • 4[2]Gradin KA,Li JY,Andersson O,et al.Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.J Vasc Res,2003,40:252-265.
  • 5[3]Almeida RS,Ferrari MF,Fior-Chadi DR.Quantitative autoradiography of adrenergic,neuropeptide Y and angiotensin Ⅱ receptors in the nucleus tractus solitarii and hypothalamus of rats with experimental hypertension.Gen Pharmacol,2000,34:343-348.
  • 6[4]Bischoff A,Gerbracht A,Michel MC.Gender and hypertension interact to regulate neuropeptide Y receptor responsiveness.Naunyn-Schmiedeberg's,Arch Pharmacol,2000,361:173-180.
  • 7[5]Odar-Cederlof I,Ericsson F,Theodorsson E,et al.Is neuropeptide Y a contributor to volume-induced hypertension? Am J Kidney Dis,1998,31:803-808.
  • 8[7]Bell D,Allen AR,Kelso EJ,et al.Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload.J Pharmacol Exp Ther,2002,303:581-591.
  • 9[8]Zeng C,Zhou Y,Liu G,et al.The signal transduction pathway causing the synergistic hypertrophic effects of neuropeptide Y and norepinephrine on primary cardiomyocyte.Neuropeptides,2001,35:211-218.
  • 10[9]Peng YX,Shan J,Qi XY,et al.The catecholamine-beta-adrenoreceptor-cAMP system and prediction of cardiovascular events in hypertension.Clin Exp Pharmcol Physiol,2006,33:227-231.

共引文献42

同被引文献47

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部